Scarica l'app Stockscreener
13.97
0.29%
0.04
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché VTYX Giù?
Forum
Previsione
Precedente Chiudi:
$13.93
Aprire:
$13.94
Volume 24 ore:
2.51M
Relative Volume:
0.85
Capitalizzazione di mercato:
$1.00B
Reddito:
-
Utile/perdita netta:
$-192.96M
Rapporto P/E:
-4.2333
EPS:
-3.3
Flusso di cassa netto:
$-167.04M
1 W Prestazione:
+0.07%
1M Prestazione:
+0.79%
6M Prestazione:
+390.18%
1 anno Prestazione:
+731.55%
Intervallo 1D:
$13.93
$13.97
Intervallo di 1 settimana:
$13.91
$13.97
Portata 52W:
$0.783
$25.00
Ventyx Biosciences Inc Stock (VTYX) Company Profile
Nome
Ventyx Biosciences Inc
Settore
Industria
Telefono
(760) 407-6511
Indirizzo
12790 EL CAMINO REAL, SUITE 200, SAN DIEGO
Compare VTYX vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VTYX
Ventyx Biosciences Inc
|
13.97 | 999.48M | 0 | -192.96M | -167.04M | -3.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.47 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.17 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
821.96 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.40 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.07 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
Ventyx Biosciences Inc Stock (VTYX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-05 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2024-03-12 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2024-03-12 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-11-07 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2023-11-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-07 | Downgrade | Oppenheimer | Outperform → Perform |
| 2023-11-07 | Downgrade | Stifel | Buy → Hold |
| 2023-11-07 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-06-14 | Ripresa | Credit Suisse | Outperform |
| 2023-03-21 | Iniziato | Wells Fargo | Overweight |
| 2022-12-19 | Iniziato | Goldman | Buy |
| 2022-11-17 | Iniziato | Morgan Stanley | Overweight |
| 2022-09-07 | Iniziato | Stifel | Buy |
| 2022-09-01 | Iniziato | H.C. Wainwright | Buy |
| 2022-05-09 | Iniziato | Credit Suisse | Outperform |
| 2022-03-31 | Iniziato | Canaccord Genuity | Buy |
| 2022-02-01 | Iniziato | Oppenheimer | Outperform |
| 2021-11-15 | Iniziato | Jefferies | Buy |
| 2021-11-15 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Ventyx Biosciences Inc Borsa (VTYX) Ultime notizie
Can Ventyx Biosciences Inc. stock hit record highs again2025 Biggest Moves & Risk Controlled Stock Pick Alerts - mfd.ru
Eli Lilly, Ventyx Biosciences receive early termination from US FTC - MLex
Halper Sadeh LLC is Investigating Whether VAL, STKL, VTYX are Obtaining Fair Deals for their Shareholders - GlobeNewswire
Ventyx Biosciences Investor Alert: Kahn Swick & Foti, LLC Investi - The National Law Review
Panic Selling: Does Ventyx Biosciences Inc have a sustainable dividendForecast Cut & Long-Term Growth Portfolio Plans - baoquankhu1.vn
Ventyx Biosciences Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Ventyx Biosciences, Inc.VTYX - Business Wire
Halper Sadeh LLC Encourages STEL, GORO, SKYT, VTYX Shareholders to Contact the Firm to Discuss Their Rights - InsideNoVa.com
SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--SKYT, GORO, STEL, and VTYX - Benzinga
Does Ventyx Biosciences Inc offer margin of safetyWeekly Profit Report & High Accuracy Trade Signal Alerts - baoquankhu1.vn
Lilly-Ventyx US premerger waiting period set to expire Feb. 23 - MLex
Ventyx Biosciences Sets March 3, 2026 Vote on Eli Lilly $14-Per-Share Cash Merger - TipRanks
Aug Movers: Is QMCO stock a hidden gemEarnings Performance Report & Stepwise Trade Signal Implementation - baoquankhu1.vn
Chipmakers Recap: Does Ventyx Biosciences Inc meet Warren Buffetts criteriaJuly 2025 Technicals & Growth Focused Entry Reports - baoquankhu1.vn
Short Interest in Ventyx Biosciences, Inc. (NASDAQ:VTYX) Drops By 37.7% - MarketBeat
Will Ventyx Biosciences Inc. benefit from rate cutsEarnings Beat & Daily Price Action Insights - mfd.ru
Halper Sadeh LLC Encourages NATH, VTYX, SKYT Shareholders to Contact the Firm to Discuss Their Rights - marketscreener.com
Assessing Ventyx Biosciences (VTYX) Valuation After Sharp Share Price Momentum And A High P/B Multiple - Yahoo Finance
Ventyx Biosciences (VTYX) Price Target Increased by 12.94% to 13.99 - MSN
Ventyx Biosciences Investor Alert: Kahn Swick & Foti, LLC Invest - GuruFocus
SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger—VTYX, ALEX, RVYL, and FFWM - morningstar.com
Ventyx Biosciences approves cash bonus awards for executives ahead of planned merger - Investing.com Nigeria
Ventyx Biosciences approves cash bonus awards for executives ahead of planned merger By Investing.com - Investing.com South Africa
Ventyx Biosciences Sets Special Cash Bonuses Amid Lilly Merger - TipRanks
Institution Moves: Is Ventyx Biosciences Inc forming a double bottomQuarterly Portfolio Summary & Safe Entry Trade Reports - baoquankhu1.vn
Aug Update: Can Caledonia Mining Corporation Plc be the next market leaderMarket Rally & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Does Ventyx Biosciences Inc. meet Warren Buffett’s criteria2025 Trade Ideas & Expert Curated Trade Setups - baoquankhu1.vn
Halper Sadeh Investigates Ventyx and Sun Country Transactions - Intellectia AI
Market Fear: Will Ventyx Biosciences Inc stock hit new highs in YEAR2025 Support & Resistance & Reliable Intraday Trade Plans - baoquankhu1.vn
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Nathan’s Famous, Inc. (Nasdaq – NATH), Lisata Therapeutics, Inc. (Nasdaq – LSTA), Sun Country Airlines Holdings, Inc. (NasdaqSNCY), Ventyx Biosciences, Inc. (Nasdaq - GlobeNewswire Inc.
Ventyx Biosciences, Inc. (NASDAQ:VTYX) Given Average Recommendation of "Reduce" by Analysts - MarketBeat
Published on: 2026-01-21 17:52:30 - baoquankhu1.vn
Does Ventyx Biosciences Inc. stock reflect fundamentalsPortfolio Return Summary & Weekly Top Stock Performers List - bollywoodhelpline.com
Ventyx Biosciences, Inc. (NASDAQ:VTYX) Short Interest Update - MarketBeat
Will Ventyx Biosciences Inc. stock split attract more investorsMarket Sentiment Summary & Entry Point Confirmation Alerts - bollywoodhelpline.com
Eli Lilly Acquires Ventyx Biosciences for $1.2 Billion, Strategizing Beyond Weight Management Drugs - Intellectia AI
Could Acquiring Ventyx Biosciences Send Eli Lilly Stock Soaring in 2026? - Finviz
Halper Sadeh Investigates ON24, Ventyx, and Sun Country for Potential Violations - Intellectia AI
Risk Off: Can RAPT Therapeutics Inc benefit from deglobalizationJuly 2025 Spike Watch & Stepwise Swing Trade Plans - baoquankhu1.vn
Analyst Calls: Will Ventyx Biosciences Inc stock hit new highs in YEARQuarterly Portfolio Summary & Safe Capital Growth Trade Ideas - baoquankhu1.vn
Eli Lilly Acquires Ventyx Biosciences for $1.2 Billion, Expanding Drug Pipeline - Intellectia AI
Citizens Financial Group Inc. RI Takes Position in Ventyx Biosciences, Inc. $VTYX - MarketBeat
Eli Lilly’s $1.2 Billion Acquisition of Ventyx Biosciences: Bridging the Gap Between Weight Loss and Chronic Inflammation - FinancialContent
Aug Sectors: What are Ventyx Biosciences Incs earnings expectationsWall Street Watch & Free Long-Term Investment Growth Plans - baoquankhu1.vn
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ventyx Biosciences, Inc.VTYX - yourwyominglink.com
Daily Breeze - FinancialContent
Eli Lilly Stock Rallies as Ventyx Deal Calms Wegovy Concerns - Finviz
Ventyx Biosciences Inc Azioni (VTYX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.12%
0.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):